Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Robert F. Storey

1-50 of 243 results

View this query on the Wikidata Query Service
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

scientific article published on 29 August 2015
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

scientific article published on 28 June 2011
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

scientific article
Long-term use of ticagrelor in patients with prior myocardial infarction

scientific article published on 14 March 2015
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

scientific article
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

scientific article
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

scientific article published on 26 August 2017
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

scientific article
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE

scientific article published on 23 October 2007
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

scientific article published on 23 October 2007
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

scientific article
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

scientific article
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

scientific article
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis

scientific article
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article published on 16 November 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

scientific article published on 27 June 2011
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

scientific article
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial

scientific article published on 30 August 2010
Expert position paper on air pollution and cardiovascular disease.

scientific article
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy

scientific article published on October 2010
The role of platelets in inflammation

scientific article
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

article
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

scientific article published on 25 September 2013
Antiplatelet agents for the treatment and prevention of atherothrombosis

scientific article published on 20 October 2011
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.

scientific article
Response variability to P2Y12 receptor inhibitors: expectations and reality

scientific article
The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity

scientific article published on 01 September 2000
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

scientific article
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

scientific article
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

scientific article published on 18 January 2012
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

scientific article published on 28 March 2016
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

scientific article published on 17 March 2019
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

article
Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood

scientific article (publication date: November 2001)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.

scientific article published on 09 May 2012
International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

scientific article published on October 30, 2017
Update on lipids, inflammation and atherothrombosis

article
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial

scientific article published on 06 January 2014
Association of MicroRNAs and YRNAs With Platelet Function

scientific article published on 08 December 2015
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.

scientific article published on 30 March 2016
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

scientific article published in May 2011
Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

scientific article published on 01 September 2012
Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

article
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

scientific article published on 09 July 2015
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy

scientific article
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

scientific article published on 21 October 2015
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

scientific article published on 31 December 2012
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

scientific article
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

scientific article

Paulina is supported by:

About Paulina

Help